Metagenomi Therapeutics, Inc.

Nasdaq:MGX

Biological Products, (No Diagnostic Substances)·EMERYVILLE, CA

Governanceproxy statements · beneficial ownership

Proxy Statements

2 shown

Filed	Form	Description
4/28/25	DEFA14A	DEFA14A	→
4/28/25	DEF 14A	DEF 14A	→

Ownership Filings

40 shown

Filed	Form	Description
12/8/25	4	4	→
12/8/25	4	4	→
12/8/25	4	4	→
12/8/25	4	4	→
12/1/25	4	4	→
12/1/25	4	4	→
↓